• 1. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 4. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

Comprehensive Guide to (3-Methoxy-5-nitrophenyl)boronic Acid (CAS No. 2851877-07-9): Properties, Applications, and Market Insights

(3-Methoxy-5-nitrophenyl)boronic acid (CAS No. 2851877-07-9) is a specialized boronic acid derivative that has garnered significant attention in the field of organic synthesis and pharmaceutical research. This compound, characterized by its unique methoxy and nitro functional groups, serves as a versatile building block in Suzuki-Miyaura cross-coupling reactions, a cornerstone of modern drug discovery and material science.

The molecular structure of (3-Methoxy-5-nitrophenyl)boronic acid features a boron atom bonded to a phenyl ring substituted with both methoxy (-OCH3) and nitro (-NO2) groups. This configuration imparts distinct electronic properties, making it highly reactive in palladium-catalyzed coupling reactions. Researchers often utilize this compound to synthesize complex biaryl structures, which are prevalent in many pharmaceutical intermediates and agrochemicals.

In recent years, the demand for boronic acid derivatives like (3-Methoxy-5-nitrophenyl)boronic acid has surged due to their critical role in developing targeted therapies and precision medicines. The compound's ability to facilitate C-C bond formation under mild conditions aligns with the growing trend toward green chemistry and sustainable synthesis methods. This has made it a popular choice for laboratories focusing on cancer research, neurological disorders, and antiviral drug development.

From a commercial perspective, (3-Methoxy-5-nitrophenyl)boronic acid is available in various purity grades, ranging from 95% to 99%, to meet diverse research needs. Suppliers often highlight its high stability and low toxicity, which are essential for handling in standard laboratory environments. The compound is typically packaged in amber glass bottles to protect it from light-induced degradation, ensuring long-term storage stability.

One of the most frequently asked questions about (3-Methoxy-5-nitrophenyl)boronic acid revolves around its solubility and reaction conditions. This compound is soluble in common organic solvents such as dimethyl sulfoxide (DMSO), tetrahydrofuran (THF), and methanol, but exhibits limited solubility in water. Researchers often optimize reaction parameters like temperature, catalyst loading, and base selection to achieve high yields in coupling reactions.

The synthesis of (3-Methoxy-5-nitrophenyl)boronic acid typically involves the lithiation-borylation of appropriately substituted aryl halides, followed by careful purification steps. Advanced analytical techniques such as nuclear magnetic resonance (NMR) spectroscopy and high-performance liquid chromatography (HPLC) are employed to confirm its purity and structural integrity. These quality control measures are crucial for ensuring reproducible results in downstream applications.

Looking ahead, the market for (3-Methoxy-5-nitrophenyl)boronic acid is expected to grow steadily, driven by increasing R&D investments in personalized medicine and bioconjugation technologies. Its compatibility with microwave-assisted synthesis and flow chemistry platforms further enhances its appeal to modern pharmaceutical manufacturers seeking to streamline production processes. As the scientific community continues to explore novel boron-containing compounds, this derivative remains a valuable tool for cutting-edge research.

For researchers working with (3-Methoxy-5-nitrophenyl)boronic acid, proper storage conditions are paramount. The compound should be kept in a cool, dry place away from moisture and strong oxidizers. Many suppliers provide detailed technical data sheets and safety guidelines to ensure safe handling practices. Its compatibility with automated synthesis platforms makes it particularly useful for high-throughput screening in drug discovery programs.

In conclusion, (3-Methoxy-5-nitrophenyl)boronic acid (CAS No. 2851877-07-9) represents a critical reagent in contemporary organic synthesis. Its unique structural features, combined with broad applicability in medicinal chemistry and material science, underscore its importance in scientific advancement. As research into boron-based therapeutics expands, this compound will likely play an increasingly prominent role in developing next-generation pharmaceuticals and functional materials.

• 1538623-40-3(3-AMINO-5-METHOXYPHENYLBORONIC ACID)
• 1072945-93-7(3-(4-Nitrophenoxy)phenylboronic Acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)